Jiangbo Pharmaceuticals to Attend CCG China Rising Investment Conference and BMC 2010 Life Sciences Summit

LAIYANG, China, May 13 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), today announced that Ms. Elsa Sung, the Company's Chief Financial Officer, will participate in the upcoming CCG China Rising Investment Conference and Brean Murray, Carret & Co. 2010 Life Sciences Summit on May 17, 2010.

    CCG China Rising Investment Conference
    Time:            Monday, May 17, 2010
    Presentation:    4:00 pm ET
    Location:        Grand Hyatt New York, 109 East 42nd Street, New York

    Brean Murray, Carret & Co. 2010 Life Sciences Summit
    Time:            Monday, May 17, 2010
    Location:        Grand Hyatt New York, 109 East 42nd Street, New York

Please contact the respective representatives for each conference to set up one-on-one meetings with the management at the conferences.

About Jiangbo Pharmaceuticals, Inc.

Jiangbo Pharmaceuticals is engaged in the research, development, production, marketing and sales of pharmaceutical products in China. The Company's operations are located in Eastern China in an Economic Development Zone in Laiyang City, Shandong Province. Jiangbo produces both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary (sticky syrup) form. For additional information, please visit the Company's website ( http://www.jiangbopharma.com ).

    For more information, please contact:

    Jiangbo Pharmaceuticals, Inc.
     Ms. Elsa Sung, CFO
     Phone: +1-954-903-9378 x2
     Email: [email protected]
     Web:   http://www.jiangbopharma.com

    CCG Investor Relations
     Ms. Lei Huang, Account Manager
     Phone: +1-646-833-3417
     Email: [email protected]
     Web:   http://www.ccgirasia.com

     Mr. Crocker Coulson, President
     Phone: +1-646-213-1915
     Email: [email protected]

SOURCE Jiangbo Pharmaceuticals, Inc.